Clorox Co: Form 10-Q for the period ended Dec 31, 2020
Filed with the SEC on Feb 4, 2021 and accepted by EDGAR at Feb 4, 2021, 16:16 ET.
Management's discussion and analysis
As filed, 42,577 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(Dollars in millions, except per share data)
Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is designed to provide a reader of The Clorox Company’s (the Company or Clorox) financial statements with a narrative from the perspective of management on the Company’s financial condition, results of operations, liquidity and certain other factors that may affect future results. The following discussion of the Company’s financial condition and results of operations should be read in conjunction with MD&A and the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020, which was filed with the Securities and Exchange Commission (SEC) on August 13, 2020, and the unaudited condensed consolidated financial statements and related notes contained in this Quarterly Report on Form 10-Q (this Report). Unless otherwise noted, MD&A compares the three and six month periods ended December 31, 2020 (the current period) to the three and six month periods ended December 31, 2019 (the prior period), with percentage and basis point calculations based on rounded numbers, except for per share data and the effective tax rate.
EXECUTIVE OVERVIEW
Clorox is a leading multinational manufacturer and marketer of consumer and professional products with approximately 8,800 employees worldwide. Clorox sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, drug, pet and military stores, third-party and owned e-commerce channels, and distributors. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products, Pine-Sol® cleaners; Liquid-Plumr® clog removers; Poett® home care products; Fresh Step® cat litter; Glad® bags and wraps; Kingsford® grilling products; Hidden Valley® dressings; Brita® water-filtration products; Burt’s Bees® natural personal care products; and RenewLife®, Rainbow Light®, Natural Vitality®, NeoCell® and Stop Aging Now® vitamins, minerals and supplements. The Company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro™ and the Clorox Healthcare® brand names. The Company has operations in more than 25 countries or territories and sells its products in more than 100 markets.
The Company primarily markets its leading brands in midsized categories considered to be financially attractive. Most of the Company’s products compete with other nationally advertised brands within each category and with “private label” brands.
The Company operates through strategic business units (SBUs) which are also the Company’s operating segments. These SBUs are then aggregated into four reportable segments. Prior periods presented have been recast to reflect the reportable segment changes effective in the fourth quarter of fiscal year 2020. The four reportable segments consist of the following:
- Health and Wellness consists of cleaning products, professional products, and vitamins, minerals and supplement products mainly marketed and sold in the U.S. Products within this segment include cleaning products such as laundry additives, including bleach products under the Clorox® brand and Clorox 2® stain fighter and color booster; home care products, primarily under the Clorox®, Clorox® Scentiva®, Formula 409®, Liquid-Plumr®, Pine-Sol® and Tilex® brands; professional cleaning and disinfecting products under the CloroxPro™, Clorox Healthcare®, and Clorox® Total 360® brands and professional food service products under the Hidden Valley® brand; and vitamins, minerals and supplement products under the RenewLife®, Rainbow Light®, Natural Vitality®, NeoCell® and Stop Aging Now® brands.
- Household consists of grilling products; bags and wraps; and cat litter products marketed and sold in the U.S. Products within this segment include grilling products under the Kingsford® and Kingsford® Match Light® brands; bags and wraps under the Glad® brand; and cat litter products under the Fresh Step®, Scoop Away® and Ever Clean® brands.
- Lifestyle consists of food products, water-filtration systems and filters, and natural personal care products marketed and sold in the U.S. Products within this segment include dressings and sauces, primarily under the Hidden Valley® brand; water-filtration systems and filters under the Brita® brand; and natural personal care products under the Burt’s Bees® brand.
- International consists of products sold outside the U.S. Products within this segment include laundry additives; home care products; water-filtration systems and filters; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products primarily under the Clorox®, Ayudin®, Clorinda®, Poett®, Pine-Sol®, Glad®, Brita®, RenewLife®, Ever Clean® and Burt’s Bees® brands.
RECENT EVENTS RELATED TO COVID-19
The novel coronavirus (COVID-19) pandemic has caused a severe global health crisis, along with economic and societal disruptions and uncertainties. As a result, we have taken an active role in addressing the ongoing pandemic’s impact on our employees, operations, customers, consumers, and communities, including taking precautionary measures, such as implementing contingency plans, making operational adjustments where necessary, and providing support to organizations that support front-line workers. The impact of COVID-19 and responses of governments, consumers, and others to the pandemic are affecting our business in many ways; however, we believe that the actions we are taking will help us emerge from this global pandemic operationally sound, and well positioned for continued long-term growth.
For our fiscal second quarter ended December 31, 2020, we continued to experience increased demand for many of our products, especially our disinfecting cleaning products, in response to COVID-19. The extent of COVID-19’s effect on our operational and financial performance in the future will depend on future developments, including the duration, spread and intensity of the pandemic, our continued ability to manufacture and distribute our products, as well as any future government actions affecting consumers and the economy generally, all of which are uncertain and difficult to predict considering the rapidly evolving landscape.
For additional information on the impacts and our response to the coronavirus pandemic, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Exhibit 99.1 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020.
RESULTS OF OPERATIONS
CONSOLIDATED RESULTS
| Three Months Ended 12/31/2020 | 12/31/2019 | % Change | Six Months Ended 12/31/2020 | 12/31/2019 | % Change | |
|---|---|---|---|---|---|---|
| Net sales | $1,842 | $1,449 | 27% | $3,758 | $2,955 | 27% |
| Three Months Ended December 31, 2020 Percentage change versus the year-ago period Reported (GAAP) Net Sales Growth / (Decrease) | Reported Volume | Acquisitions & Divestitures | Foreign Exchange Impact | Price/Mix/Other (1) | Organic Sales Growth / (Decrease) (Non-GAAP) (2) | Organic Volume (3) | |
|---|---|---|---|---|---|---|---|
| Health and Wellness | 42% | 36% | —% | —% | 6% | 42% | 36% |
| Household | 20 | 18 | — | — | 2 | 20 | 18 |
| Lifestyle | 9 | 8 | — | — | 1 | 9 | 8 |
| International | 23 | 22 | 9 | (4) | 3 | 18 | 15 |
| Total | 27% | 24% | 1% | —% | 3% | 26% | 23% |
| Six Months Ended December 31, 2020 | |||||||
| Percentage change versus the year-ago period | |||||||
| Reported (GAAP) Net Sales Growth / (Decrease) | Reported Volume | Acquisitions & Divestitures | Foreign Exchange Impact | Price/Mix/Other (1) | Organic Sales Growth / (Decrease) (Non-GAAP) (2) | Organic Volume (3) | |
| Health and Wellness | 35% | 31% | —% | —% | 4% | 35% | 31% |
| Household | 30 | 21 | — | — | 9 | 30 | 21 |
| Lifestyle | 13 | 12 | — | — | 1 | 13 | 12 |
| International | 21 | 19 | 9 | (6) | 6 | 18 | 12 |
| Total | 27% | 24% | 1% | (1)% | 4% | 27% | 23% |
(1) This represents the net impact on net sales growth / (decrease) from pricing actions, mix and other factors.
(2) Organic sales growth / (decrease) is defined as net sales growth / (decrease) excluding the effect of any acquisitions and divestitures as well as changes in foreign exchange rates. See “Non-GAAP Financial Measures” below for reconciliation of organic sales growth / (decrease) to net sales growth, the most directly comparable GAAP financial measure.
(3) Organic volume represents volume excluding the effect of any acquisitions and divestitures. In the three months ended December 31, 2020, the volume impact of acquisitions was 7% and 1% for International and Total Company, respectively. In the six months ended December 31, 2020, the volume impact of acquisitions was 7% and 1% for International and Total Company, respectively.
Net sales in the current three month period increased by 27%, reflecting higher shipments across all reportable segments driven by increased demand due to COVID-19 and related behavioral shifts, including people spending more time at home. Volume increased by 24% versus the prior period. The variance between volume growth and net sales growth was primarily due to the impact of lower trade promotion spending and favorable mix.
Net sales in the current six month period increased by 27%, reflecting higher shipments across all reportable segments driven by increased demand due to COVID-19 and related behavioral shifts, including people spending more time at home. Volume increased by 24% versus the prior period. The variance between volume growth and net sales growth was primarily due to the impact of favorable mix, partially offset by unfavorable foreign currency exchange rates.
| Three Months Ended 12/31/2020 | 12/31/2019 | % Change | Six Months Ended 12/31/2020 | 12/31/2019 | % Change | |
|---|---|---|---|---|---|---|
| Gross profit | $837 | $639 | 31% | $1,757 | $1,302 | 35% |
| Gross margin | 45.4% | 44.1% | 46.8% | 44.1% |
Gross margin, defined as gross profit as a percentage of net sales, increased by 130 basis points in the current three month period from 44.1% to 45.4%. The increase was primarily driven by higher volume, cost savings and lower trade promotion spending, partially offset by higher manufacturing and logistics costs.
Gross margin increased by 270 basis points in the current six month period from 44.1% to 46.8%. The increase was primarily driven by higher volume, cost savings and favorable mix, partially offset by higher manufacturing and logistics costs.
| Three Months Ended 12/31/2020 | 12/31/2019 | % Change | % of Net Sales 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|---|
| Selling and administrative expenses | $269 | $210 | 28% | 14.6% | 14.5% |
| Advertising costs | 187 | 140 | 34 | 10.2 | 9.7 |
| Research and development costs | 40 | 34 | 18 | 2.2 | 2.3 |
| Six Months Ended | |||||
| % of Net Sales | |||||
| 12/31/2020 | 12/31/2019 | % Change | 12/31/2020 | 12/31/2019 | |
| Selling and administrative expenses | $507 | $421 | 20% | 13.5% | 14.2% |
| Advertising costs | 366 | 277 | 32 | 9.7 | 9.4 |
| Research and development costs | 72 | 64 | 13 | 1.9 | 2.2 |
Selling and administrative expenses, as a percentage of net sales, increased by 10 basis points and decreased by 70 basis points in the current three and six month periods, respectively. The dollar increase in selling and administrative expenses was primarily due to higher incentive compensation expenses, consistent with the Company’s performance-based compensation philosophy, as well as increased investments in several growth opportunities.
Advertising costs, as a percentage of net sales, increased by 50 basis points and 30 basis points in the current three and six month periods, respectively. The increase in advertising expenses reflected the Company’s continued support behind its brands. The Company’s U.S. retail advertising spend as a percentage of net sales was approximately 11% in the current and prior three month periods.
Research and development costs, as a percentage of net sales, decreased by 10 basis points and 30 basis points in the current three and six month periods, respectively; however, were essentially flat in terms of dollars. The Company continues to invest behind product innovation and cost savings.
Interest expense, Other (income) expense, net, and the effective tax rate on earnings
| Three Months Ended 12/31/2020 | 12/31/2019 | Six Months Ended 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Interest expense | $24 | $25 | $49 | $50 |
| Other (income) expense, net | (15) | (5) | (95) | (3) |
| Effective tax rate on earnings | 21.2% | 21.0% | 20.9% | 21.3% |
Other (income) expense, net was ($15) and ($5) in the current and prior three month periods, respectively, and ($95) and ($3) in the current and prior six month periods, respectively. The variance between the current and prior three month periods was not significant. The variance between the current and prior six month periods was primarily due to the one-time, non-cash remeasurement gain recognized in the current period from the Company’s previously held equity interest in its joint venture in the Kingdom of Saudi Arabia (Saudi joint venture) in the first quarter of fiscal year 2021 (see Notes to Condensed Consolidated Financial Statements).
The effective tax rate on earnings was 21.2% and 20.9% in the current three and six month periods, respectively, and 21.0% and 21.3% for the prior three and six month periods, respectively. In comparison to the prior six month period, the lower effective tax rate was primarily due to higher excess tax benefits and the non-taxability of a portion of the remeasurement gain recognized on the Company’s previously held investment in the Saudi joint venture, partially offset by a reduced benefit from releases of uncertain tax positions.
Diluted net earnings per share
| Three Months Ended 12/31/2020 | 12/31/2019 | % Change | Six Months Ended 12/31/2020 | 12/31/2019 | % Change | |
|---|---|---|---|---|---|---|
| Diluted net earnings per share | $2.03 | $1.46 | 39% | $5.25 | $3.05 | 72% |
Diluted net earnings per share (EPS) increased by $0.57, or 39%, in the current three month period, primarily due to net sales growth, gross margin expansion, partially offset by higher selling and administrative expenses and advertising investments.
Diluted net earnings per share increased by $2.20, or 72%, in the current six month period, primarily due to net sales growth, gross margin expansion, the remeasurement gain recognized on the previously held equity interest in the Saudi joint venture, partially offset by higher selling and administrative expenses and advertising investments.
SEGMENT RESULTS
The following presents the results of operations from the Company’s reportable segments and certain unallocated costs reflected in Corporate (see Notes to Condensed Consolidated Financial Statements for a reconciliation of segment results to consolidated results):
Health and Wellness
| Three Months Ended 12/31/2020 | 12/31/2019 | % Change | Six Months Ended 12/31/2020 | 12/31/2019 | % Change | |
|---|---|---|---|---|---|---|
| Net sales | $817 | $575 | 42% | $1,630 | $1,208 | 35% |
| Earnings before income taxes | 247 | 134 | 84 | 498 | 304 | 64 |
Volume, net sales and earnings before income taxes increased by 36%, 42% and 84%, respectively, during the current three month period. The volume and sales growth were primarily fueled by an increase in demand for cleaning and disinfecting products across the Cleaning and Professional Products portfolios due to greater demand inside and outside the home. The variance between volume and net sales was primarily due to favorable mix and lower trade promotion spending. The increase in earnings before income taxes was primarily due to net sales growth, partially offset by higher manufacturing and logistics costs and higher advertising investments.
Volume, net sales and earnings before income taxes increased by 31%, 35% and 64%, respectively, during the current six month period. The volume and sales growth reflected higher shipments in all strategic business units primarily fueled by an increase in demand for cleaning and disinfecting products across the Cleaning and Professional Products portfolios due to greater demand inside and outside the home. The variance between volume and net sales was primarily due to favorable mix. The increase in earnings before income taxes was primarily due to net sales growth, partially offset by higher manufacturing and logistics costs and higher advertising investments.
Household
| Three Months Ended 12/31/2020 | 12/31/2019 | % Change | Six Months Ended 12/31/2020 | 12/31/2019 | % Change | |
|---|---|---|---|---|---|---|
| Net sales | $411 | $342 | 20% | $911 | $703 | 30% |
| Earnings before income taxes | 60 | 44 | 36 | 169 | 76 | 122 |
Volume, net sales and earnings before income taxes increased by 18%, 20% and 36%, respectively, during the current three month period. The volume growth reflected higher shipments across all strategic business units from higher consumer demand. The variance between volume and net sales was primarily due to lower trade promotion spending. The increase in earnings before income taxes was mainly due to net sales growth, partially offset by higher manufacturing and logistics costs and higher advertising investments.
Volume, net sales and earnings before income taxes increased by 21%, 30% and 122%, respectively, during the current six month period. The volume growth reflected higher shipments across all strategic business units, mainly in Grilling and Litter primarily driven by inventory replenishment at key retailers to meet strong consumer demand and Bags and Wraps, which also benefited from higher consumer demand. The variance between volume and net sales was primarily due to favorable mix and lower trade promotion spending. The increase in earnings before income taxes was mainly due to net sales growth, partially offset by higher manufacturing and logistics costs and higher advertising investments.
Lifestyle
| Three Months Ended 12/31/2020 | 12/31/2019 | % Change | Six Months Ended 12/31/2020 | 12/31/2019 | % Change | |
|---|---|---|---|---|---|---|
| Net sales | $317 | $291 | 9% | $635 | $562 | 13% |
| Earnings before income taxes | 89 | 91 | (2) | 191 | 162 | 18 |
Volume and net sales increased by 8% and 9%, respectively, and earnings before income taxes decreased by 2% during the current three month period. Both volume growth and net sales growth were primarily driven by higher shipments of Food and Brita water filtration products mainly due to greater demand by consumers and strategic brand investments. The Natural Personal Care business declined as the brand continued to adapt to new consumer shopping and usage habits. The decrease in earnings before income taxes was primarily due to higher manufacturing and logistics costs and higher advertising investments, partially offset by net sales growth.
Volume, net sales and earnings before income taxes increased by 12%, 13% and 18%, respectively, during the current six month period. Both volume growth and net sales growth were primarily driven by higher shipments of Food and Brita water filtration products mainly due to greater demand by consumers and strategic brand investments. The Natural Personal Care business declined as the brand continued to adapt to new consumer shopping and usage habits. The increase in earnings before income taxes was primarily due to net sales growth, partially offset by higher manufacturing and logistics costs.
International
| Three Months Ended 12/31/2020 | 12/31/2019 | % Change | Six Months Ended 12/31/2020 | 12/31/2019 | % Change | |
|---|---|---|---|---|---|---|
| Net sales | $297 | $241 | 23% | $582 | $482 | 21% |
| Earnings before income taxes | 30 | 31 | (3) | 154 | 70 | 120 |
Volume and net sales increased by 22% and 23%, respectively, and earnings before income taxes decreased by 3% during the current three month period. The volume increase was primarily driven by higher shipments from ongoing demand for disinfecting and other household products in every geographic region, as well as the impact of the Saudi joint venture acquisition. The variance between volume and net sales was mainly due to favorable mix and the benefit of price increases implemented to offset inflation, partially offset by the impact of unfavorable foreign currency exchange rates. The decrease in earnings before income taxes was primarily due to higher advertising investments, unfavorable foreign currency exchange rates, and higher manufacturing and logistics costs, partially offset by net sales growth.
Volume, net sales and earnings before income taxes increased by 19%, 21% and 120% respectively, during the current six month period. The volume increase was primarily driven by higher shipments from ongoing demand for disinfecting and other household products in every geographic region, as well as the impact of the Saudi joint venture acquisition. The variance between volume and net sales was mainly due to favorable mix and the benefit of price increases implemented to offset inflation, partially offset by the impact of unfavorable foreign currency exchange rates. The increase in earnings before income taxes was primarily due to the remeasurement gain recognized on the previously held equity interest in the Saudi joint venture.
Argentina
Effective July 1, 2018, under the requirements of U.S. GAAP, Argentina was designated as a highly inflationary economy, and as a result the U.S. dollar replaced the Argentine peso as the functional currency of the Company’s subsidiaries in Argentina. Consequently, gains and losses from non-U.S. dollar denominated monetary assets and liabilities of Clorox Argentina are recognized in Other (income) expense, net in the consolidated statement of earnings. The business environment in Argentina continues to be challenging due to significant volatility in Argentina’s currency, high inflation, an economic recession and impacts of COVID-19 that include temporary strict price controls. As of December 31, 2020 and June 30, 2020, the net asset position, excluding goodwill, of Clorox Argentina was $43 and $44, respectively. Of these net assets, cash balances were approximately $9 and $19 as of December 31, 2020 and June 30, 2020, respectively. Net sales from Clorox Argentina represented approximately 2% of the Company’s consolidated net sales for the six months ended December 31, 2020 and the fiscal year ended June 30, 2020.
For additional information on the impacts of, and our response to, the business environment in Argentina, refer to “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020.
Corporate
Corporate includes certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses.
| Three Months Ended 12/31/2020 | 12/31/2019 | % Change | Six Months Ended 12/31/2020 | 12/31/2019 | % Change | |
|---|---|---|---|---|---|---|
| Losses before income taxes | $(94) | $(65) | 45% | $(154) | $(119) | 29% |
Losses before income taxes increased by $29 in the current three month period and $35 in the current six month period primarily due to higher employee and incentive compensation expenses.
FINANCIAL POSITION AND LIQUIDITY
The Company’s financial condition and liquidity remained strong as of December 31, 2020. The following table summarizes cash activities:
| Six Months Ended 12/31/2020 | 12/31/2019 | |
|---|---|---|
| Net cash provided by operations | $629 | $498 |
| Net cash used for investing activities | (258) | (98) |
| Net cash used for financing activities | (524) | (338) |
Operating Activities
Net cash provided by operations was $629 in the current six month period, compared with $498 in the prior six month period. The increase was primarily driven by the Company’s profitable sales growth, partially offset by higher tax payments and higher employee incentive compensation payments made in the current six month period versus the prior period. The year-over-year increase was also driven by a reduction in net working capital (higher Accounts payable and accrued liabilities partially offset by higher inventories, both primarily to meet increased customer demand).
Investing Activities
Net cash used for investing activities was $258 in the current six month period, compared with $98 in the prior six month period. The year-over-year increase was mainly due to the acquisition of additional interest in the Company’s Saudi joint venture and higher capital spending to increase capacity in the current six month period.
Financing Activities
Net cash used for financing activities was $524 in the current six month period, compared with $338 in the prior six month period. The year-over-year increase was mainly due to higher treasury stock repurchases in the current six month period and net cash sourced from short-term borrowings in the prior period.
Capital Resources and Liquidity
Global financial markets have experienced a significant increase in volatility due to heightened uncertainty over the adverse economic impact caused by the COVID-19 outbreak. Notwithstanding these potential adverse market conditions, the Company believes it will have the funds necessary to support our short-term liquidity and operating needs based on our anticipated ability to generate positive cash flows from operations in the future, access to capital markets enabled by our strong short-term and long-term credit ratings, and current borrowing availability under the credit agreement.
Credit Arrangements
As of December 31, 2020, the Company maintained a $1,200 revolving credit agreement that matures in November 2024 (the Credit Agreement). There were no borrowings under the Credit Agreement as of December 31, 2020 and June 30, 2020, and the Company believes that borrowings under the Credit Agreement are and will continue to be available for general corporate purposes. The Credit Agreement includes certain restrictive covenants and limitations. The primary restrictive covenant is a minimum ratio of 4.0, calculated as total earnings before interest, taxes, depreciation and amortization and non-cash asset impairment charges (Consolidated EBITDA) to total interest expense for the trailing four quarters (Interest Coverage ratio), as defined and described in the Credit Agreement.
The following table sets forth the calculation of the Interest Coverage ratio as of December 31, 2020, using Consolidated EBITDA for the trailing four quarters, as contractually defined in the Credit Agreement:
| Twelve Months Ended 12/31/2020 | |
|---|---|
| Net earnings | $1,229 |
| Add back: | |
| Interest expense | 98 |
| Income tax expense | 321 |
| Depreciation and amortization | 196 |
| Non-cash asset impairment charges | 2 |
| Deduct: | |
| Interest income | (3) |
| Non-recurring, non-cash gain(1) | (85) |
| Consolidated EBITDA | $1,758 |
| Interest expense | $98 |
| Interest Coverage ratio | 17.9 |
(1) Non-recurring, non-cash gain from the remeasurement of the Company’s previously held investment in its Saudi joint venture (see Notes to Condensed Consolidated Financial Statements).
The Company was in compliance with all restrictive covenants and limitations in the Credit Agreement as of December 31, 2020, and anticipates being in compliance with all restrictive covenants for the foreseeable future. The Company continues to monitor the financial markets and assess its ability to continue to draw on the Credit Agreement, and currently expects it will continue to have access to borrowings under the Credit Agreement.
As of December 31, 2020, the Company maintained $35 of foreign and other credit lines, of which $2 was outstanding.
Stock Repurchases and Dividend Payments
As of December 31, 2020, the Company had two stock repurchase programs: an open-market purchase program with an authorized aggregate purchase amount of up to $2,000, which has no expiration date, and a program to offset the anticipated impact of dilution related to stock-based awards (the Evergreen Program), which has no authorization limit on the dollar amount and no expiration date.
Stock repurchases under the two stock repurchase programs were as follows for the periods indicated:
| Three Months Ended 12/31/2020 Amount | Shares (in thousands) | 12/31/2019 Amount | Shares (in thousands) | Six Months Ended 12/31/2020 Amount | Shares (in thousands) | 12/31/2019 Amount | Shares (in thousands) | |
|---|---|---|---|---|---|---|---|---|
| Open-market purchase program | $— | — | $85 | 577 | $— | — | $85 | 577 |
| Evergreen Program | 200 | 980 | — | — | 300 | 1,424 | 104 | 663 |
| Total stock repurchases | $200 | 980 | $85 | 577 | $300 | 1,424 | $189 | 1,240 |
Dividends per share declared and total dividends paid to Clorox stockholders were as follows for the periods indicated:
| Three Months Ended 12/31/2020 | 12/31/2019 | Six Months Ended 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Dividends per share declared | $1.11 | $1.06 | $2.22 | $2.12 |
| Total dividends paid | 140 | 133 | 280 | 266 |
27
CONTINGENCIES
See Notes to Condensed Consolidated Financial Statements for information on the Company’s contingencies.
RECENTLY ISSUED ACCOUNTING STANDARDS
See Notes to Condensed Consolidated Financial Statements for a summary of recently issued accounting standards relevant to the Company.
NON-GAAP FINANCIAL MEASURES
The non-GAAP financial measures that are included in this MD&A and the reasons management believes they are useful to investors are described below. These measures should be considered supplemental in nature and are not intended to be a substitute for the related financial information prepared in accordance with U.S. GAAP. In addition, these measures may not be the same as similarly named measures presented by other companies.
The Company uses the term Consolidated EBITDA because it is a term used in the Credit Agreement. As defined in the Credit Agreement, Consolidated EBITDA represents earnings before interest, taxes, depreciation and amortization, non-cash asset impairment charges and other non-cash, non-recurring gains or losses. Interest Coverage ratio is the ratio of Consolidated EBITDA to interest expense. The Company’s management believes disclosure of Consolidated EBITDA provides useful information to investors because it is used in determining compliance with the primary restrictive covenant in the Credit Agreement. For additional discussion of the Interest Coverage ratio and a reconciliation of Consolidated EBITDA to net earnings, see “Financial Position and Liquidity - Financing Activities - Credit Arrangements” above.
Organic sales growth / (decrease) is defined as net sales growth / (decrease) excluding the effect of foreign exchange rate changes and any acquisitions and divestitures. Management believes that the presentation of organic sales growth / (decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the Company was operating throughout the relevant periods, and the impact of foreign exchange rate changes, which are out of the control of the Company and management.
The following table provides a reconciliation of organic sales growth / (decrease) (non-GAAP) to net sales growth / (decrease) (GAAP), the most comparable GAAP measure:
| Three Months Ended December 31, 2020 Percentage change versus the year-ago period Health and Wellness | Household | Lifestyle | International | Total | |
|---|---|---|---|---|---|
| Net sales growth / (decrease) (GAAP) | 42% | 20% | 9% | 23% | 27% |
| Add: Foreign Exchange | — | — | — | 4 | — |
| Add/(Subtract): Divestitures/Acquisitions | — | — | — | (9) | (1) |
| Organic sales growth / (decrease) (non-GAAP) | 42% | 20% | 9% | 18% | 26% |
| Six Months Ended December 31, 2020 | |||||
| Percentage change versus the year-ago period | |||||
| Health and Wellness | Household | Lifestyle | International | Total | |
| Net sales growth / (decrease) (GAAP) | 35% | 30% | 13% | 21% | 27% |
| Add: Foreign Exchange | — | — | — | 6 | 1 |
| Add/(Subtract): Divestitures/Acquisitions | — | — | — | (9) | (1) |
| Organic sales growth / (decrease) (non-GAAP) | 35% | 30% | 13% | 18% | 27% |
28
Cautionary Statement
This Quarterly Report on Form 10-Q (this Report), including the exhibits hereto and the information incorporated by reference herein, contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel coronavirus (COVID-19) pandemic, and the related responses of governments, consumers, customers, suppliers, employees and the Company, on our business, operations, employees, financial condition and results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings attributable to the Company, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management’s estimates, beliefs, assumptions and projections. Words such as “could,” “may,” “expects,” “anticipates,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “will,” “predicts,” and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations, or could affect the Company’s ability to achieve its strategic goals, are described in the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020 and in this Report, as updated from time to time in the Company’s Securities and Exchange Commission filings. These factors include, but are not limited to, the uncertainties relating to the continued impact of COVID-19 on the Company’s business, operations, employees, financial condition and results of operations, as well as:
- intense competition in the Company’s markets;
- the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences;
- the impact of COVID-19 on the availability of, and efficiency of the supply, manufacturing and distribution systems for, the Company’s products, including any significant disruption to such systems;
- long-term changes in consumer preference or demand for the Company’s products as a result of any shortages or lack of availability of any products in the near-term;
- risks related to supply chain issues and product shortages as a result of reliance on a limited base of suppliers and the significant increase in demand for disinfecting and other products due to the COVID-19 pandemic;
- dependence on key customers and risks related to customer consolidation and ordering patterns;
- risks related to the Company’s use of and reliance on information technology systems, including potential security breaches, cyber-attacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or Company information, or service interruptions, especially at a time when a large number of the Company’s employees are working remotely and accessing its technology infrastructure remotely;
- risks relating to acquisitions, including the recent acquisition of the majority interest in the Company’s Saudi joint venture, new ventures and divestitures, and associated costs, including for asset impairment charges related to, among others, intangible assets and goodwill; and the ability to complete announced transactions and, if completed, integration costs and potential contingent liabilities related to those transactions;
- unfavorable worldwide, regional and local economic and financial market conditions, including as a result of fear of exposure to or actual impacts of a widespread disease outbreak, such as COVID-19;
- the Company’s ability to maintain its business reputation and the reputation of its brands and products;
- lower revenue, increased costs or reputational harm resulting from government actions and regulations;
- the ability of the Company to successfully manage global political, legal, tax and regulatory risks, including changes in regulatory or administrative activity;
- the ability of the Company to drive sales growth, increase prices and market share, grow its product categories and manage favorable product and geographic mix;
- volatility and increases in commodity costs such as resin, sodium hypochlorite and agricultural commodities, and increases in energy, transportation or other costs;
- risks related to international operations and international trade, including foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls, including periodic changes in such controls; changes in U.S. immigration or trade policies, including the imposition of new or additional tariffs; labor claims and labor unrest; inflationary pressures, particularly in Argentina; impact of the United Kingdom’s exit from, and the related on-going negotiations with, the European Union; government-imposed price controls or other regulations; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; widespread health emergencies, such as COVID-19; and the possibility of nationalization, expropriation of assets or other government action;
- the facilities of the Company and its suppliers being subject to disruption by events beyond the Company’s control, including work stoppages, cyber-attacks, natural disasters, disease outbreaks or pandemics, such as COVID-19, and terrorism;
- the ability of the Company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries;
- the impact of product liability claims, labor claims and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls;
- the ability of the Company to implement and generate cost savings and efficiencies;
- the success of the Company’s business strategies;
- risks related to additional increases in the estimated fair value of The Procter & Gamble Company’s interest in the Glad business;
- the accuracy of the Company’s estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based;
- the Company’s ability to attract and retain key personnel;
- environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances;
- increased focus by governmental and non-governmental organizations, customers, consumers and investors on sustainability issues, including those related to climate change;
- the Company’s ability to effectively utilize, assert and defend its intellectual property rights;
- any infringement or claimed infringement by the Company of third-party intellectual property rights;
- the effect of the Company’s indebtedness and credit rating on its business operations and financial results;
- the Company’s ability to access capital markets and other funding sources, as well as continued or increased market volatility;
- the Company’s ability to pay and declare dividends or repurchase its stock in the future;
- uncertainties relating to tax positions, tax disputes and any changes in tax rates and regulations on the Company;
- the Company’s ability to maintain an effective system of internal controls;
- the impacts of potential stockholder activism; and
- risks related to the Company’s discontinuation of operations in Venezuela.
The Company’s forward-looking statements in this Report are based on management’s current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this Report. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.
In this Report, unless the context requires otherwise, the terms “the Company,” “Clorox,” “we,” “us,” and “our” refer to The Clorox Company and its subsidiaries.
Market risk
As filed, 325 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have not been any material changes to the Company’s market risk since June 30, 2020. For additional information, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Exhibit 99.1 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020.
Controls and procedures
As filed, 1,163 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this Report, were effective such that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
No change in the Company’s internal control over financial reporting occurred during the second fiscal quarter of the fiscal year ending June 30, 2021, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-10-01 to 2020-12-31 | $1.84bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2020-07-01 to 2020-12-31 | $3.76bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2020-10-01 to 2020-12-31 | $1.00bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2020-07-01 to 2020-12-31 | $2.00bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-10-01 to 2020-12-31 | $837.0m | us-gaap:GrossProfit |
| Gross profit | 6 months2020-07-01 to 2020-12-31 | $1.76bn | us-gaap:GrossProfit |
| Research and development | 3 months2020-10-01 to 2020-12-31 | $40.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2020-07-01 to 2020-12-31 | $72.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2020-10-01 to 2020-12-31 | $269.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2020-07-01 to 2020-12-31 | $507.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2020-10-01 to 2020-12-31 | $24.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2020-07-01 to 2020-12-31 | $49.0m | us-gaap:InterestExpense |
| Income tax | 3 months2020-10-01 to 2020-12-31 | $71.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2020-07-01 to 2020-12-31 | $180.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-10-01 to 2020-12-31 | $259.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2020-07-01 to 2020-12-31 | $674.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-10-01 to 2020-12-31 | $2.03 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2020-07-01 to 2020-12-31 | $5.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-10-01 to 2020-12-31 | $2.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2020-07-01 to 2020-12-31 | $5.34 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-10-01 to 2020-12-31 | 128,135,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2020-07-01 to 2020-12-31 | 128,457,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2020-07-01 to 2020-12-31 | $629.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2020-07-01 to 2020-12-31 | $151.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2020-07-01 to 2020-12-31 | $280.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2020-07-01 to 2020-12-31 | $300.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-12-31 | $732.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $2.10bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $6.86bn | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $1.74bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $5.47bn | us-gaap:Liabilities |
| Long-term debt | At period end2020-12-31 | $2.48bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2020-12-31 | $300.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2020-12-31 | $1.18bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000021076-21-000004. Last ingested by Listed: Nov 10, 2026, 22:57 ET. Listed shows no prices and gives no investment advice.